ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Pain Medicine

Top Pain Medicine Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARIA CABODEVILLA-CONN MD

Pain Medicine

728

$65.5K

139
54 are 65+

65%
patients receiving schedule two controlled substances

Avg: 30%

31%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$90
Average prescription price

Avg: $100

STEVEN CALVINO M.D.

Pain Medicine

632

$56.4K

63
41 are 65+

40%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 24%

$89
Average prescription price

Avg: $100

SAMANT VIRK MD

Pain Medicine

564

$46.7K

130
71 are 65+

30%
patients receiving schedule two controlled substances

Avg: 30%

8%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $100

ELIZABETH CHANDLER MD

Pain Medicine

774

$63.4K

194
49 are 65+

71%
patients receiving schedule two controlled substances

Avg: 30%

37%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$82
Average prescription price

Avg: $100

STACEY JAFF M.D.

Pain Medicine

169

$13.7K

27
0 are 65+

48%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$81
Average prescription price

Avg: $100

LUKE RIGOLOSI MD

Pain Medicine

499

$38.8K

140
103 are 65+

19%
patients receiving schedule two controlled substances

Avg: 30%

39%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 24%

$78
Average prescription price

Avg: $100

ADAKU NWACHUKU D.O.

Pain Medicine

569

$44K

162
51 are 65+

67%
patients receiving schedule two controlled substances

Avg: 30%

15%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$77
Average prescription price

Avg: $100

RENEE MELFI MD

Pain Medicine

911

$68.9K

193
157 are 65+

7%
patients receiving schedule two controlled substances

Avg: 30%

14%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $100

DANIEL KOHANE M.D.

Pain Medicine

638

$47.8K

123
71 are 65+

59%
patients receiving schedule two controlled substances

Avg: 30%

25%
patients receiving schedule three controlled substances

Avg: 18%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$75
Average prescription price

Avg: $100

ALEXANDER LEE MD

Pain Medicine

832

$61.5K

229
193 are 65+

15%
patients receiving schedule two controlled substances

Avg: 30%

21%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $100

SAJID KHAN M.D.

Pain Medicine

576

$39.9K

158
83 are 65+

42%
patients receiving schedule two controlled substances

Avg: 30%

37%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $100

ARASH YADEGAR M.D.

Pain Medicine

383

$26.4K

145
102 are 65+

29%
patients receiving schedule two controlled substances

Avg: 30%

23%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $100

DMITRY NESEN M.D.

Pain Medicine

351

$23.9K

59
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $100

EVAN QUELER M.D.

Pain Medicine

201

$13.3K

75
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $100

KIOOMARS MOOSAZADEH MD

Pain Medicine

1,013

$64.9K

394
323 are 65+

13%
patients receiving schedule two controlled substances

Avg: 30%

12%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $100

SUNIL ALBERT M.D.

Pain Medicine

1,249

$79.6K

154
101 are 65+

47%
patients receiving schedule two controlled substances

Avg: 30%

21%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $100

LUCIANO TULUCA MD

Pain Medicine

1,267

$80K

204
120 are 65+

46%
patients receiving schedule two controlled substances

Avg: 30%

17%
patients receiving schedule three controlled substances

Avg: 18%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $100

JOSEPH BAX D.O.

Pain Medicine

546

$34.1K

131
78 are 65+

57%
patients receiving schedule two controlled substances

Avg: 30%

24%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $100

JOHN VLATTAS MD

Pain Medicine

641

$40K

103
46 are 65+

35%
patients receiving schedule two controlled substances

Avg: 30%

50%
patients receiving schedule three controlled substances

Avg: 18%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $100

STEVEN WEINSTEIN M.D.

Pain Medicine

506

$31.2K

110
69 are 65+

25%
patients receiving schedule two controlled substances

Avg: 30%

35%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $100

MUHAMMAD KHAN MD

Pain Medicine

2,347

$139K

129
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $100

ANNA KROL M.D.

Pain Medicine

293

$17.1K

63
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $100

JEFFREY PERRY DO

Pain Medicine

270

$15.4K

124
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $100

SYED RAHMAN M.D.

Pain Medicine

640

$35.8K

139
102 are 65+

12%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $100

VIDYASAGAR MOKUREDDY M.D.

Pain Medicine

762

$41.4K

264
123 are 65+

60%
patients receiving schedule two controlled substances

Avg: 30%

30%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $100

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank